公司执行董事李海涛已获委任为行政总裁及授权代表，以接替秦杰的职务，自2025年10月15日起生效。 港仔机器人(00370)发布公告，秦杰因其他个人事务已辞任执行董事，自2025年10月15日起生效。紧随 其辞任后，秦杰亦将不再担任行政总裁以及香港联合交易所有限公司证券上市规则第3.05条规定的授权 代表之一。 ...

董事局进一步宣布，公司执行董事李海涛已获委任为行政总裁及授权代表，以接替秦杰的职务，自2025 年10月15日起生效。 格隆汇10月15日丨港仔机器人(00370.HK)宣布，秦杰因其他个人事务已辞任执行董事，自2025年10月15 日起生效。 ...

公司执行董事李海涛已获委任为行政总裁及授权代表，以接替秦杰的职务，自2025年10月15日起生效。 智通财经APP讯，港仔机器人(00370)发布公告，秦杰因其他个人事务已辞任执行董事，自2025年10月15 日起生效。紧随其辞任后，秦杰亦将不再担任行政总裁以及香港联合交易所有限公司证券上市规则第 3.05条规定的授权代表之一。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確 性或完整性亦不發表任何聲明，亦明確表示概不就因本公佈全部或任何部份內容而產生或因 倚賴該等內容而引致之任何損失承擔任何責任。 Hong Kong Robotics Group Holding Limited 港仔機器人集團控股有限公司 （於百慕達註冊成立之有限公司） （股份代號：370） 執行董事、行政總裁及授權代表辭任 及 委任行政總裁及授權代表 港仔機器人集團控股有限公司（「本公司」，連同其附屬公司統稱「本集團」）董事（「董事」）局 （「董事局」）謹此宣佈，秦杰先生（「秦先生」）因其他個人事務已辭任執行董事，自二零二五年 十月十五日起生效。緊隨其辭任後，秦先生亦將不再擔任行政總裁以及香港聯合交易所有限 公司證券上市規則第3.05條規定的授權代表（「授權代表」）之一。秦先生已確認其與董事局並 無分歧，且就其辭任事宜並無其他事宜需提請本公司股東垂注。 董事局進一步宣佈，本公司執行董事李海濤先生（「李先生」）已獲委任為行政總裁及授權代 表，以接替秦先生的職務，自二零二五年十月十五日起生效。 1 ╱ 於本公佈日期，李先生個人持有本公 ...

截至月份: 2025年9月30日 狀態: 新提交 FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 致：香港交易及結算所有限公司 公司名稱: 港仔機器人集團控股有限公司（於百慕達註冊成立之有限公司） 呈交日期: 2025年10月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00370 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 25,000,000,000 | HKD | | 0.1 HKD | | 2,500,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 25,000,000,000 | HKD | | 0.1 HKD | | 2,500,000,000 ...

Core Viewpoint - The partnership between 港仔机器人 and 达闼机器人 marks a significant milestone in the development of humanoid robots in Hong Kong, with 港仔机器人 obtaining exclusive rights to over 2000 patents in embodied intelligence from 达闼机器人 [1][3]. Group 1: Strategic Collaboration - The collaboration integrates 港仔机器人的 financial resources and market application capabilities with 达闼's extensive patent portfolio in cloud intelligence and robotics technology [3]. - 港仔机器人 has developed its own "XR-OS Embodied Intelligence Brain Operating System," achieving full-link intelligence in perception, cognition, decision-making, and control [3]. - The hardware advancements include the mass production of SCA joint modules with 0.1mm motion precision and 600Nm peak torque, enabling complex operations in various environments [3]. Group 2: Market Applications and Achievements - 港仔机器人 has demonstrated significant market application capabilities, signing a strategic cooperation agreement worth over 800 million HKD with health management giant 美年健康 to deploy 20,000 smart health robots [4]. - The company has secured a 300 million HKD order for 1,000 security robots and a record-breaking order for 10,000 home care robots, establishing a leading position in the industry [4]. - The "Robot as a Service" (RaaS) business model will lower initial deployment barriers for users, expanding market opportunities [4]. Group 3: Recent Collaborations and Market Performance - 港仔机器人 has engaged in multiple collaborations with mainland companies this year, including agreements with 华为云计算 and 云深处科技 for comprehensive cooperation in humanoid robots and embodied intelligence applications [5]. - The company's stock has surged by 420% this year, with a market capitalization of 2.72 billion HKD [5].

Core Viewpoint - The collaboration between 港仔机器人 and 达闼机器人 marks a significant milestone in the development of humanoid robots in Hong Kong, with 港仔机器人 obtaining exclusive rights to nearly 2000 patents from 达闼, indicating strong confidence in the humanoid robot industry and the technological leadership of 达闼 [1][2] Group 1: Strategic Collaboration - The partnership is described as a "strong union" between two leading companies in the field of embodied intelligence, with 港仔机器人 leveraging its advantages in financial resource integration and market expansion, while 达闼 contributes its extensive technological expertise and nearly 2000 patents [2][4] - The collaboration aims to create an industry leader in the embodied intelligence robot sector by integrating resources across Hong Kong and mainland China, finance and technology, as well as application and research [2] Group 2: Technological Advancements - 港仔机器人的 core competitiveness is significantly enhanced through the acquisition of 达闼's patents, enabling the development of its own "XR-OS embodied intelligence brain operating system" that achieves full-chain intelligence in perception, cognition, decision-making, and control [4] - The company has overcome hardware challenges, achieving mass production of high-precision SCA joint modules with 0.1mm motion accuracy and 600Nm peak torque, allowing for complex operations in various environments [4] Group 3: Market Impact and Business Development - 港仔机器人 has demonstrated strong market application capabilities, signing a strategic cooperation agreement worth over 800 million with health management giant 美年健康 to deploy 20,000 smart health robots [7] - The company has also secured significant orders, including a 300 million order for 1000 security robots and a record-breaking order for 10,000 home care robots, enhancing its competitive position in various sectors [7] - The "robot as a service" (RaaS) business model is expected to lower initial deployment barriers for users, further expanding market opportunities [7] Group 4: Implications for Hong Kong's Tech Industry - The collaboration is seen as a vital contribution to Hong Kong's innovation and technology development, promoting local manufacturing of humanoid robots and aligning with the vision of "Hong Kong innovation, world standards" [9] - 港仔机器人 has rapidly established itself in the AI and humanoid robot sector, achieving significant market recognition and a more than fourfold increase in market value since March of this year [9] - The partnership positions 港仔机器人 to lead the industry into a new phase of practical and efficient development, potentially creating sustainable returns for investors and setting a "Hong Kong model" for the global embodied intelligence robot industry [9]

Core Viewpoint - The collaboration between 港仔机器人 and 达闼机器人 marks a significant milestone in the humanoid robotics industry, with 港仔机器人 receiving exclusive authorization for nearly 2000 patents from 达闼, indicating strong confidence in the sector and the technology involved [1][2]. Group 1: Strategic Collaboration - The partnership is described as a "strong union," combining 港仔机器人的 advantages in financial resource integration and market expansion with 达闼机器人的 deep technological expertise and innovation [2]. - The collaboration aims to create an industry leader in the embodied intelligence robotics field by integrating resources across multiple dimensions, including finance, technology, application, and operations [2]. Group 2: Technological Advancements - 港仔机器人的 core competitiveness is significantly enhanced through the acquisition of 达闼's patents, enabling the development of an advanced operating system that achieves full-chain intelligence in perception, cognition, decision-making, and control [5]. - The company has overcome hardware challenges, achieving mass production of high-precision components, which supports complex operations in various environments [5]. Group 3: Market Applications and Achievements - 港仔机器人 has demonstrated substantial market application capabilities, securing strategic agreements worth over 800 million with health management giant 美年健康 to deploy 20,000 smart health robots [8]. - The company has also achieved record-breaking orders, including a 3 billion order for 1000 security robots and the first global order for 10,000 home care robots, enhancing its competitive edge in various sectors [8]. Group 4: Impact on Hong Kong's Tech Industry - The collaboration is pivotal for Hong Kong's innovation and technology sector, promoting local manufacturing of humanoid robots and aligning with the vision of "Hong Kong innovation, world standards" [10]. - 港仔机器人 is positioned to lead the industry into a new phase of practicality and efficiency, potentially creating sustainable returns for investors and setting a benchmark for the global embodied intelligence robotics industry [10].

Group 1 - The company, 港仔机器人 (00370), announced the appointment of 邱毅勇 as a non-executive director and vice chairman of the board, effective from September 23, 2025 [1]

Group 1 - The company, 港仔机器人, announced the appointment of Mr. Huang Xiaoqing as the Group's Chief Scientist, effective from September 23, 2025 [1]